Pharma Stock Roundup ABBV to Buy Immunogen, NVS Ups Mid ... - Nasdaq
| 278650 Stock | KRW 1,980 25.00 1.25% |
About 61% of KNOTUS CoLtd's investor base is looking to short. The analysis of current outlook of investing in KNOTUS CoLtd suggests that many traders are alarmed regarding KNOTUS CoLtd's prospects. The current market sentiment, together with KNOTUS CoLtd's historical and current headlines, can help investors time the market. In addition, many technical investors use KNOTUS CoLtd stock news signals to limit their universe of possible portfolio assets.
KNOTUS |
Pharma Stock Roundup ABBV to Buy Immunogen, NVS Ups Mid ... Nasdaq
Read at news.google.com
 |
KNOTUS CoLtd Fundamental Analysis
We analyze KNOTUS CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KNOTUS CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KNOTUS CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
KNOTUS CoLtd is rated third in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
KNOTUS CoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with KNOTUS CoLtd stock to make a market-neutral strategy. Peer analysis of KNOTUS CoLtd could also be used in its relative valuation, which is a method of valuing KNOTUS CoLtd by comparing valuation metrics with similar companies.
Peers
KNOTUS CoLtd Related Equities
| 288330 | Bridge Biotherapeutics | 14.09 | ||||
| 225220 | Genolution | 4.13 | ||||
| 215380 | WOOJUNG BIO | 3.03 | ||||
| 293780 | AptaBio Therapeutics | 2.27 | ||||
| 278650 | KNOTUS CoLtd | 1.25 | ||||
| 217330 | Cytogen | 3.83 |
Complementary Tools for KNOTUS Stock analysis
When running KNOTUS CoLtd's price analysis, check to measure KNOTUS CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KNOTUS CoLtd is operating at the current time. Most of KNOTUS CoLtd's value examination focuses on studying past and present price action to predict the probability of KNOTUS CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KNOTUS CoLtd's price. Additionally, you may evaluate how the addition of KNOTUS CoLtd to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |